Analyst Recommendations

Susquehanna analyst issues NEUTRAL recommendation for DXC on June 12, 2024 07:17AM ET. The previous analyst recommendation was Neutral.DXC was trading at $18.34 at issue of the analyst...

June 12, 2024   DXC -5.08%

Citigroup analyst issues NEUTRAL recommendation for ORCL on June 12, 2024 07:11AM ET. The previous analyst recommendation was Neutral.ORCL was trading at $123.88 at issue of the analyst...

June 12, 2024   ORCL -1.35%

Susquehanna analyst issues POSITIVE recommendation for XPO on June 12, 2024 07:22AM ET. The previous analyst recommendation was Positive.XPO was trading at $107.04 at issue of the analyst...

June 12, 2024   XPO -6.02%

Cantor Fitzgerald analyst issues OVERWEIGHT recommendation for ZURA on June 12, 2024 07:23AM ET. ZURA was trading at $3.83 at issue of the analyst recommendation.The overall analyst consensus...

June 12, 2024   ZURA -7.98%

Piper Sandler analyst issues OVERWEIGHT recommendation for MTB on June 12, 2024 07:25AM ET. The previous analyst recommendation was Overweight.MTB was trading at $140.83 at issue of the...

June 12, 2024   MTB -3.83%

RBC Capital analyst issues OUTPERFORM recommendation for NEE on June 12, 2024 07:33AM ET. The previous analyst recommendation was Outperform.NEE was trading at $72.74 at issue of the...

June 12, 2024   NEE -0.43%

Oppenheimer analyst issues OUTPERFORM recommendation for MRNA on June 12, 2024 07:41AM ET. The previous analyst recommendation was Outperform.MRNA was trading at $148.39 at issue of the analyst...

June 12, 2024   MRNA -2.54%

Oppenheimer analyst issues OUTPERFORM recommendation for FSLR on June 12, 2024 07:39AM ET. The previous analyst recommendation was Outperform.FSLR was trading at $294.53 at issue of the analyst...

June 12, 2024   FSLR -3.58%

BMO Capital analyst issues MARKET PERFORM recommendation for META on June 12, 2024 07:47AM ET. The previous analyst recommendation was Market Perform.META was trading at $507.47 at issue...

June 12, 2024   META -3.85%

Wedbush analyst issues OUTPERFORM recommendation for ACN on June 12, 2024 07:48AM ET. The previous analyst recommendation was Outperform.ACN was trading at $294.22 at issue of the analyst...

June 12, 2024   ACN -4.40%